MedPath

Study on examining how biological markers impact treatment outcomes for anal cancer patients undergoing chemo and radiation therapy

Not Applicable
Conditions
Health Condition 1: C211- Malignant neoplasm of anal canal
Registration Number
CTRI/2024/05/066973
Lead Sponsor
Mahamana Pandit Madanmohan Malaviya Cancer Centre and Homi Bhabha Cancer Hospital, Varanasi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Histological diagnosis of Squamous cell carcinoma of anal canal.

-Patients being treated with curative intent with concurrent chemo- radiotherapy (CTRT)

-Age of patient 18 years or older

-ECOG status 0 – 2

-Patient consenting for participation in study (Written informed consent for prospective patients, Telephonic informed consent for retrospective patients)

Exclusion Criteria

-Unwilling to participate in the study.

-Presence of distant metastases.

-Medical condition precluding curative intent treatment for the patient.

-History of previous treatment for current condition.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath